Select Page

Landie owners help cover costs for treatment of young cancer patient

Landie owners help cover costs for treatment of young cancer patient

A 7-year-old cancer patient, Dantel Swart, has just received a substantial donation from the Land Rover Owners Namibia club, to help cover the extensive medical costs for her treatment.

The Landie owners have collected this money at last year’s Battle of the Brands for Cancer offroad event hosted at the Tony Rust race track outside Windhoek where a record 58 entries vied for the grand prize.

“Land Rover Owners Namibia is deeply grateful to all participants, sponsors and donors for their support, as now- although with delays due to the lockdown – we were finally able to identify and give much needed financial assistance of N$50,000 to Dantel for cancer treatment,” the club said in a statement announcing their contribution.

Dantel started life with the odds stacked against her. She was born severely premature at only 24 weeks but she pulled through and grew into a sparkling young girl. Even during the worst of her cancer treatment, she always have a radiating smile, encouraging all those around her to keep their spirits up.

Last year she was diagnosed with a cancer that attacks the bones and surrounding soft tissue. Typically it is a cancer that appears in adolescents or young adults. The cancer is treatable with a good prognosis but in Dantel’s case, the cancer formed a lesion on her left lung with a diameter of 7cm, pressing against her rib and heart. After bone scans, sonars, MRI scans, CT scans, bone marrow extraction and port insertions, Dantel finally started her first cycle of chemo in the middle of last year. The removal of the tumour and part of her 8th rib followed in November and continued with aggressive radiation for two months.

Her treatment is done at the Unitas Hospital in Pretoria where she receives chemo every second week if her body allows it. The treatment itself has a devastating effect on her body. She is nauseous, lost her hair, her eyesight has weakened and she is on heart medication. This aggressive treatment, which is almost coming to an end, is her only chance. Afterwards, she will still have to undergo two years of maintenance treatment.


 

About The Author

Mandisa Rasmeni

Mandisa Rasmeni has worked as reporter at the Economist for the past five years, first on the entertainment beat but now focussing more on community, social and health reporting. She is a born writer and is working on her degree in Journalism at the Namibia University of Science and Technology (NUST). She believes education is the greatest equalizer. She is the epitome of perseverance, having started as the newspaper's receptionist in 2013.